Callahan, Alex J.
Gandhesiri, Satish
Travaline, Tara L. http://orcid.org/0000-0002-7218-8650
Reja, Rahi M.
Lozano Salazar, Lia
Hanna, Stephanie
Lee, Yen-Chun
Li, Kunhua
Tokareva, Olena S.
Swiecicki, Jean-Marie http://orcid.org/0000-0002-7139-8621
Loas, Andrei
Verdine, Gregory L. http://orcid.org/0000-0002-2195-364X
McGee, John H. http://orcid.org/0000-0002-3440-5247
Pentelute, Bradley L. http://orcid.org/0000-0002-7242-801X
Funding for this research was provided by:
FOG Pharmaceuticals Inc.
Article History
Received: 29 June 2023
Accepted: 26 January 2024
First Online: 28 February 2024
Competing interests
: The authors declare the following competing interest(s): B.L.P. is a co-founder and/or member of the scientific advisory board of several companies focusing on the development of protein and peptide therapeutics. T.L.T., K.L., O.S.T., G.L.V., and J.H.M. are currently employed by FOG Pharmaceuticals, and G.L.V. serves on the board of directors of FOG Pharmaceuticals. FOG Pharmaceuticals has filed provisional patent applications related to the compounds described in this work. J.M.S. was an employee of FOG Pharmaceuticals and is currently employed by Relay Therapeutics, Inc.